Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Accredited Facilities
14%
Adjusted Hazard Ratio
28%
Adjuvant Chemoradiation
100%
Adjuvant Radiation Therapy
14%
Adjuvant Therapy
14%
Adverse Features
14%
Commission on Cancer
14%
Concurrent Chemoradiation
28%
Cox Regression Analysis
14%
Extranodal Extension
100%
Head-and-neck Cancer
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
71%
Human Papillomavirus Negative
100%
Multivariable
14%
National Cancer Database
14%
Negative Margins
14%
Node Positive
57%
Non-associated
28%
Overall Survival
100%
Pathologic
85%
Prognostic Significance
28%
Radiation Therapy
28%
Retrospective Cohort Study
28%
Medicine and Dentistry
Adjuvant
14%
Adjuvant Therapy
14%
Chemoradiotherapy
100%
Hazard Ratio
28%
Head and Neck Cancer
100%
Head and Neck Squamous Cell Carcinoma
71%
Malignant Neoplasm
28%
Overall Survival
100%
Proportional Hazards Model
14%
Radiation Therapy
42%
Retrospective Cohort Study
28%
Wart Virus
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
14%
Chemoradiation Therapy
100%
Cohort Study
28%
Head and Neck Cancer
100%
Head and Neck Squamous Cell Carcinoma
71%
Human Papillomavirus
100%
Malignant Neoplasm
28%
Overall Survival
100%
Nursing and Health Professions
Adjuvant
14%
Adjuvant Therapy
14%
Chemoradiotherapy
100%
Cohort Analysis
28%
Hazard Ratio
28%
Head and Neck Cancer
100%
Head and Neck Squamous Cell Carcinoma
71%
Malignant Neoplasm
28%
Overall Survival
100%
Proportional Hazards Model
14%
Radiotherapy
42%